Journal Information
Vol. 36. Issue 2.
Pages 61-63 (February 2000)
Share
Share
Download PDF
More article options
Vol. 36. Issue 2.
Pages 61-63 (February 2000)
Full text access
Monitorización de fármacos antituberculosos. ¿Tiene utilidad en la clínica?
Visits
8431
M.L. de Souza, R. Vidal*
Servicio de Neumología. Hospital Vall d’Hebron. Barcelona
This item has received
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
Pou L, Campos F. A clinical chemistry therapeutic drug monitoring service. En: Decker, editor. Recent developments in therapeutic drug monitoring, clinical toxicology. I Sunshine (ed.) Palo Alto, California, 1992, 9-13.
[2.]
C.A. Peloquin, R. Namdar, M.D. Singleton, D.E. Nix.
Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids.
Chest Med, 115 (1999), pp. 12-18
[3.]
C.A. Peloquin.
Rifampin stability.
Ther Drug Monit, 20 (1998), pp. 450-451
[4.]
C.A. Peloquin.
Therapeutic drug monitoring in antituberculosis chemotherapy.
Ther Drug Monit, 21 (1999), pp. 426-427
[5.]
D.A. Mitchison.
Basic mechanisms of chemotherapy.
Chest, 76 (1979), pp. 771-781
[6.]
C.A. Peloquin.
Therapeutic drug monitoring: principles and application in mycobacterial infections.
Drug Ther, 22 (1992), pp. 31-36
[7.]
S.E. Berning, G.A. Huitt, M.D. Iseman, C.A. Peloquin.
Malabsorption of antituberculosis medications by a patient with AIDS.
N Engl J Med, 327 (1992), pp. 1817-1818
[8.]
K.B. Patel, R. Belmonte, H.M. Crowe.
Drug malabsorption and resistant tuberculosis in HIV-infected patients.
N Engl J Med, 332 (1995), pp. 336-337
[9.]
M. Lutfey, P. Della-Lata, V. Kapur.
Independent origin of mono-rifampin- resistant Mycobacterium tuberculosis in patients with AIDS..
Am J Respir Crit Care Med, 153 (1996), pp. 837-840
[10.]
M.L. De Souza, M. Miravitlles, I. Andrés, F. Nicolau, L. Pou, R. Vidal.
Monitorización de las concentraciones plasmáticas de fármacos antituberculosos.
Estudio piloto. Arch Bronconeumol, 34 (1998), pp. 12
[11.]
J. Sahai, K. Gallicano, L. Swick, S. Tailor, G. Garber, I. Seguin, et al.
Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection.
Ann Intern Med, 127 (1997), pp. 289-293
[12.]
S. Choudhri, M. Hawken, S. Gathua, G. Minyri, W. Watkins, J. Sahai, et al.
Pharmacokinetics of antimycobacterial drugs in patients with tuberculosis AIDS, and diarrhea..
CID, 25 (1997), pp. 104-111
[13.]
M. Kimerling, P. Phillips, P. Patterson, M. Hall, A. Robinson, N. Dunlap.
Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients.
Chest, 113 (1998), pp. 1178-1183
[14.]
B. Taylor, P. Smith.
Does AIDS impair the absorption of antituberculosis agents?.
Int J Tuberc Lung Dis, 2 (1998), pp. 670-675
[15.]
M.L. De Souza, M. Miravitlles, E. Rodríguez, I. Andrés, L. Pou, R. Vidal.
Determinación del perfil farmacocinético de rifampicina, isoniacida y pirazinamida en un grupo de enfermos tuberculosos con terapia triple.
Arch Bronconeumol, 35 (1999), pp. 45
Copyright © 2000. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?